| Kourtney L Steinkamp, NP | |
|
611 W. Park St., Hvi, Urbana, IL 61801 | |
| (217) 904-7000 | |
| Not Available |
| Full Name | Kourtney L Steinkamp |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 611 W. Park St., Urbana, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033684170 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 209018286 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Carle Foundation Hospital | Urbana, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carle Health Care Incorporated | 3577515774 | 808 |
News Archive
When researchers at Cornell, the University of Bonn and the University of Pittsburgh transplanted living embryonic heart cells into cardiac tissue of mice that had suffered heart attacks, the mice became resistant to cardiac arrhythmias, thereby avoiding one of the most dangerous and fatal consequences of heart attacks.
The World Health Organisation declared the Ebola virus outbreak a public health emergency in August 2014; since then the development of vaccines against Ebola virus has been fast tracked.
Optimer Pharmaceuticals, announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company's novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection.
Researchers report in the current issue of Mayo Clinic Proceedings that more than one-half of their study patients were unable to list their medications, diagnoses, treatment plan (names and purposes of medications) and common side effects of prescribed medications.
› Verified 3 days ago
| Entity Name | Carle Health Care Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154653947 PECOS PAC ID: 3577515774 Enrollment ID: O20100513000829 |
News Archive
When researchers at Cornell, the University of Bonn and the University of Pittsburgh transplanted living embryonic heart cells into cardiac tissue of mice that had suffered heart attacks, the mice became resistant to cardiac arrhythmias, thereby avoiding one of the most dangerous and fatal consequences of heart attacks.
The World Health Organisation declared the Ebola virus outbreak a public health emergency in August 2014; since then the development of vaccines against Ebola virus has been fast tracked.
Optimer Pharmaceuticals, announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company's novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection.
Researchers report in the current issue of Mayo Clinic Proceedings that more than one-half of their study patients were unable to list their medications, diagnoses, treatment plan (names and purposes of medications) and common side effects of prescribed medications.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kourtney L Steinkamp, NP 611 W. Park St, Fapc, Urbana, IL 61801 Ph: (217) 902-5291 | Kourtney L Steinkamp, NP 611 W. Park St., Hvi, Urbana, IL 61801 Ph: (217) 904-7000 |
News Archive
When researchers at Cornell, the University of Bonn and the University of Pittsburgh transplanted living embryonic heart cells into cardiac tissue of mice that had suffered heart attacks, the mice became resistant to cardiac arrhythmias, thereby avoiding one of the most dangerous and fatal consequences of heart attacks.
The World Health Organisation declared the Ebola virus outbreak a public health emergency in August 2014; since then the development of vaccines against Ebola virus has been fast tracked.
Optimer Pharmaceuticals, announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company's novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection.
Researchers report in the current issue of Mayo Clinic Proceedings that more than one-half of their study patients were unable to list their medications, diagnoses, treatment plan (names and purposes of medications) and common side effects of prescribed medications.
› Verified 3 days ago
Lindy Drollinger, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 610 N. Lincoln Ave., Neurosurgery, Urbana, IL 61801 Phone: 217-383-3507 Fax: 217-383-3171 | |
Emily Remington, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-383-3140 Fax: 217-383-4966 | |
Kendall E Wallace, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-383-3311 | |
Jiaqiu Sinha, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 509 W University Ave, Urbana, IL 61801 Phone: 217-383-6645 | |
Mrs. Doris M Lawyer, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1109 S Lincoln Ave, Urbana, IL 61801 Phone: 217-333-2711 | |
Peter Kale, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1818 E. Windsor Road, Adult Medicine/geriatrics, Urbana, IL 61802 Phone: 217-255-9672 Fax: 217-383-4681 | |
Kelly Johnson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1818 E. Windsor Road, Urbana, IL 61802 Phone: 217-255-9670 Fax: 217-255-9724 |